Literature DB >> 18853967

Continuing rapid increase in esophageal adenocarcinoma in England and Wales.

Côme Lepage1, Bernard Rachet, Valérie Jooste, Jean Faivre, Michel P Coleman.   

Abstract

BACKGROUND AND AIMS: Substantial changes have occurred in the epidemiology of esophageal adenocarcinoma. We examined trends in incidence in a large national population.
METHODS: All esophageal adenocarcinomas registered in England and Wales over a 31-year period (1971-2001) were included. Incidence rates were calculated by age, sex, and socio-economic category, by 5-year period, and by birth cohort.
RESULTS: A total of 43,753 esophageal adenocarcinomas were analyzed. Age-standardized (world) incidence rates rose rapidly, by an average of 39.6% (95% CI 38.6-40.6) every 5 years in men, and 37.5% (35.8-39.2) every 5 years in women. Incidence has increased about three-fold in men and women since 1971. Incidence has risen in all deprivation categories since 1986, especially in the most affluent groups. The cumulative risk of esophageal adenocarcinoma over the age range 15-74 years in men rose ten-fold, from 0.1% for those born in 1900 to 1.1% for those born in 1940. The cumulative risk rose five-fold in women.
CONCLUSIONS: The incidence of esophageal adenocarcinoma has increased sharply over the past few decades, both by period and birth cohort. Etiological studies are required to explain the rapid increase of this lethal cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18853967     DOI: 10.1111/j.1572-0241.2008.02191.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  101 in total

1.  Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis.

Authors:  Deirdre P Cronin-Fenton; Liam J Murray; David C Whiteman; Chris Cardwell; Penelope M Webb; Susan J Jordan; Douglas A Corley; Linda Sharp; Jesper Lagergren
Journal:  Eur J Cancer       Date:  2010-04-22       Impact factor: 9.162

2.  Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia.

Authors:  Hannah P Kim; William J Bulsiewicz; Cary C Cotton; Evan S Dellon; Melissa B Spacek; Xiaoxin Chen; Ryan D Madanick; Sarina Pasricha; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2012-06-23       Impact factor: 9.427

3.  Are We Making Progress in Preventing Barrett's-Related Esophageal Cancer?

Authors:  Julian A Abrams
Journal:  Therap Adv Gastroenterol       Date:  2009-03       Impact factor: 4.409

4.  The definition and management of Barrett's oesophagus: a case report, review of the literature and a suggestion for the future.

Authors:  Elizabeth Louise Bird-Lieberman; Pierre Lao-Sirieix; Ibitsam Saeed; David Khoo; Rodney Burnham; Rebecca Fitzgerald
Journal:  BMJ Case Rep       Date:  2009-06-01

5.  Increasing incidence of Barrett's oesophagus: a population-based study.

Authors:  Helen G Coleman; Shivaram Bhat; Liam J Murray; Damian McManus; Anna T Gavin; Brian T Johnston
Journal:  Eur J Epidemiol       Date:  2011-06-14       Impact factor: 8.082

6.  Durability and predictors of successful radiofrequency ablation for Barrett's esophagus.

Authors:  Sarina Pasricha; William J Bulsiewicz; Kelly E Hathorn; Srinadh Komanduri; V Raman Muthusamy; Richard I Rothstein; Herbert C Wolfsen; Charles J Lightdale; Bergein F Overholt; Daniel S Camara; Evan S Dellon; William D Lyday; Atilla Ertan; Gary W Chmielewski; Nicholas J Shaheen
Journal:  Clin Gastroenterol Hepatol       Date:  2014-05-09       Impact factor: 11.382

7.  Low expression of cyclinH and cyclin-dependent kinase 7 can decrease the proliferation of human esophageal squamous cell carcinoma.

Authors:  Jianguo Zhang; Xiaojing Yang; Yuchan Wang; Hui Shi; Chengqi Guan; Li Yao; Xianting Huang; Zongmei Ding; Yuejiao Huang; Huijie Wang; Chun Cheng
Journal:  Dig Dis Sci       Date:  2013-03-02       Impact factor: 3.199

8.  Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett's esophagus with radiofrequency ablation.

Authors:  Eric S Orman; Hannah P Kim; William J Bulsiewicz; Cary C Cotton; Evan S Dellon; Melissa B Spacek; Xiaoxin Chen; Ryan D Madanick; Sarina Pasricha; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2012-12-18       Impact factor: 10.864

9.  Adherence to WCRF/AICR lifestyle recommendations for cancer prevention and the risk of Barrett's esophagus onset and evolution to esophageal adenocarcinoma: results from a pilot study in a high-risk population.

Authors:  Stefano Realdon; Alessandro Antonello; Diletta Arcidiacono; Elisa Dassie; Francesco Cavallin; Matteo Fassan; Maria Teresa Nardi; Alfredo Alberti; Massimo Rugge; Giorgio Battaglia
Journal:  Eur J Nutr       Date:  2015-07-10       Impact factor: 5.614

Review 10.  Early diagnosis of oesophageal cancer.

Authors:  E L Bird-Lieberman; R C Fitzgerald
Journal:  Br J Cancer       Date:  2009-06-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.